Hints and tips:
Related Special Reports
...The project will mark the foundation’s first direct investment in science infrastructure as a commercial venture within its £38bn endowment portfolio, rather than being funded through its £1.6bn-a-year research...
...To do this, closer relationships with life science companies would be needed, argued Sinker, who is also chief executive of Cambridge university Hospitals NHS Foundation Trust....
...The Pharmaceutical Accountability Foundation, which logged a claim against the company on Tuesday at a district court in Amsterdam, said in a statement that AbbVie had abused its dominant position in the...
...The number of drug trials undertaken in the UK fell by 41 per cent in the four years to 2021, “jeopardising” the long-term future of pharmaceutical research in the UK....
...In total, the foundation has invested more than DKr3bn ($400mn) on stem cell research, including a new manufacturing facility....
...Hannah Kuchler All pharmaceutical innovation takes a long time, but I think the foundation ownership did play a big role here, because it means that the company, even though it is publicly listed, is maybe...
...Once considered a relic of the 1960s counterculture, psychedelic drugs have experienced a renaissance both in society and healthcare research in the past two decades, such as the rise of “microdosing” by...
...The writer is chief executive of the Access to Medicine Foundation In 1934, Kaveri, a 19-year-old girl in Malaya, died of severe bleeding after giving birth to a baby boy. She was my grandmother....
...The number of positions offered grew by 43 per cent annually across the top 10 pharmaceutical companies alone since 2018....
...“Where there is scarcity of supply of the product, almost without exception the scarce supply will go to the highest bidder,” says Claudia Martinez, head of research at the Access to Medicine Foundation,...
...But the proposal has run into opposition from the pharmaceutical industry....
...So they set up the Novo Nordisk Foundation, which thanks to the company’s growth is now the world’s largest philanthropic foundation by assets....
...Embark Biotech was spun out from the Novo Nordisk Foundation’s centre for basic metabolic research at the University of Copenhagen in 2017....
...The drugs used were developed by the Wellcome Foundation and Glaxo Laboratories, both now part of UK-listed GSK, which posted £22bn in turnover in the first nine months of last year....
...In one example of an innovative approach to drug development, the Cystic Fibrosis Foundation used a “venture philanthropy” model to fund research and development of the drug ivacaftor....
...It now exists with the sole mission of funding scientific research in climate change and health, infectious diseases and mental health....
...They worked out how to prevent the immune system from destroying mRNA, so that its instructions to make useful proteins could be applied in pharmaceutical and vaccine development....
...The company said its prices are justified by its high packing costs and its Rmb1bn investment into research and development....
...The UK-based pharmaceutical group continued to develop M72, with funding from several aid agencies, before giving the Gates Foundation a non-exclusive licence to commercialise it in about 100 low- and middle-income...
...The California-based firm, founded in 2003 with funding from the Bill & Melinda Gates Foundation, had captured 50 per cent of the global market in squalane, a skincare humectant that mimics squalene, naturally...
...Incentivising research To keep research labs open and looking for new antibiotics, philanthropists and impact investors have tried to fill the gap that venture capitalists have left....
...The US pharmaceuticals group reported full findings of its phase 3 clinical study of donanemab at the Alzheimer’s Association International Conference in Amsterdam, showing that the antibody treatment slowed...
...Ulbrich also claimed that blood tests on some of his clients have shown them to be suffering from a “vaccine-acquired immunodeficiency syndrome” or “V-AIDS” — a syndrome that respected scientists say is...
...Mads Krogsgaard Thomsen, chief executive of the Novo Nordisk Foundation, which has the majority of voting rights in the company, described executives asking: “Why would we do such a trial with a high risk...
...This fruitless quest to transmute base metals into gold laid the foundations for systematic experimentation....
International Edition